Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Profound and sustained response with next generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
Rigaud C, Abbou S, Ducassou S, Simonin M, Le Mouel L, Pereira V, Gourdon S, Lambilliotte A, Geoerger B, Minard-Colin V, Brugieres L. Rigaud C, et al. Haematologica. 2022 May 19. doi: 10.3324/haematol.2021.280081. Online ahead of print. Haematologica. 2022. PMID: 35586965 Free article.
De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.
Babin L, Darchen A, Robert E, Aid Z, Borry R, Soudais C, Piganeau M, De Cian A, Giovannangeli C, Bawa O, Rigaud C, Scoazec JY, Couronné L, Veleanu L, Cieslak A, Asnafi V, Sibon D, Lamant L, Meggetto F, Mercher T, Brunet E. Babin L, et al. Among authors: rigaud c. Mol Cancer. 2022 Mar 4;21(1):65. doi: 10.1186/s12943-022-01520-0. Mol Cancer. 2022. PMID: 35246138 Free PMC article.
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Dourthe ME, Phulpin A, Auperin A, Bosq J, Couec ML, Dartigues P, Ducassou S, Garnier N, Haouy S, Leblanc T, Leruste A, Paillard C, Rigaud C, Simonin M, Patte C, Minard-Colin V. Dourthe ME, et al. Among authors: rigaud c. Haematologica. 2022 Mar 3. doi: 10.3324/haematol.2021.280257. Online ahead of print. Haematologica. 2022. PMID: 35236054 Free article.
Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients.
Pereira V, Boudjemaa S, Besson C, Leblanc T, Rigaud C, Leruste A, Garnier N, Lambilliotte A, Simonin M, Curtillet C, Bonneau-Lagacherie J, Coulomb A, Landman-Parker J. Pereira V, et al. Among authors: rigaud c. J Pediatr Hematol Oncol. 2022 Jan 28. doi: 10.1097/MPH.0000000000002403. Online ahead of print. J Pediatr Hematol Oncol. 2022. PMID: 35091521
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort.
González Briceño LG, Kariyawasam D, Samara-Boustani D, Giani E, Beltrand J, Bolle S, Fresneau B, Puget S, Sainte-Rose C, Alapetite C, Pinto G, Piketty ML, Brabant S, Abbou S, Aerts I, Beccaria K, Bourgeois M, Roujeau T, Blauwblomme T, Di Rocco F, Thalassinos C, Pauwels C, Rigaud C, James S, Busiah K, Simon A, Bourdeaut F, Lemelle L, Guerrini-Rousseau L, Orbach D, Touraine P, Doz F, Dufour C, Grill J, Polak M. González Briceño LG, et al. Among authors: rigaud c. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2156-e2166. doi: 10.1210/clinem/dgab893. J Clin Endocrinol Metab. 2022. PMID: 34918112
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.
Michot JM, Mouraud S, Adam J, Lazarovici J, Bigenwald C, Rigaud C, Tselikas L, Dartigues P, Danu A, Bigorgne A, Minard V, Ghez D, Marabelle A, Zitvogel L, Ribrag V. Michot JM, et al. Among authors: rigaud c. Cancers (Basel). 2021 Oct 31;13(21):5487. doi: 10.3390/cancers13215487. Cancers (Basel). 2021. PMID: 34771650 Free PMC article.
77 results